
Import of Indian drugs blocked by Pak govt
Pakistan government has blocked a proposal for importing 400 medicines from India following intense lobbying against the move by the local pharmaceutical industry.
The proposal forwarded by Pakistan's commerce ministry was stalled ahead of an expected hike of upto 40 per cent in the prices of life-saving drugs in the country.
Prime Minister Yousuf Raza Gilani has reportedly issued a direction that no drug produced in Pakistan should be imported.
Gilani also sought justification for importing from India 13 vaccines and some oncology drugs that are currently not produced in Pakistan, sources told the Dawn newspaper.
However, the import of these vaccines and oncology products will continue.
Health Secretary Khushnood Lashari will meet Commerce Secretary Asif Shah to ensure that the proposal for importing Indian drugs is closed.
Sources in the commerce ministry had leaked information about the proposal to import Indian drugs to the local pharmaceutical industry, which used its "contacts" to pre-empt the move, the daily said.
Local entrepreneurs contended that the proposed imports would threaten the jobs of over one million people, affect annual exports worth more than 120 million dollars and compromise the availability of medicines during emergencies.
Pakistan's pharmaceutical industry is worth Rs 83 billion and enjoys considerable political clout.
Meanwhile, the health ministry's advisory committee on drug prices has recommended a 10 to 40 per cent increase in prices of various life-saving drugs.

RBI proposes stricter norms for non-banks

Markets skid amid weak global cues

CSR offences by firms now a ‘civil wrong’, not a crime

Intel tumbles after new CEO recommits to chip manufacturing
- Keeping chip production in-house may be bad for Intel because its manufacturing technology has fallen behind Taiwan Semiconductor Manufacturing Co., which makes chips for many of Intel’s rivals. If the US company can’t catch up, its products will become less competitive, lose sales and market share.

Indigo Paints IPO garners robust response; subscribed 117 times on final day

India will be role model on how to vaccinate billion people at scale: Nilekani

Govt has pledged strict foreign investment rules for e-commerce, says CAIT

Iran starts ramping up oil production to pre-sanctions levels
- Iran has been subject to tough US sanctions since 2018, when the administration of then-President Donald Trump unilaterally withdrew from an international deal that restricted the Middle Eastern country’s nuclear activities. Its crude production was below 2 million barrels a day for most of 2020.

Elon Musk targets telecom for next disruption with Starlink internet

Sensex tanks 746 points; Nifty ends below 14,375

Google parent-company shutting Loon, balloon-based alternative to cell towers

How traditional finance management methods by women continue to be relevant now

Airbus slows production ramp-up, cites virus hit to demand

Invest in mutual funds but steer clear of ‘Herd Mentality’!
